Series E funding round for Antiva Biosciences raising $53M in April 2023
Series E funding round for Antiva Biosciences raising $53M in April 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$137M
Top Valuation
-
Antiva Biosciences raised $53M in a Series E round.
The round was announced on 04/01/23.